MasterControl Risk Analysis™ - Risk Analysis Software System
Software System for Automating Risk Analysis Processes
Risk management is one of the central goals of quality operations. Whether reporting a nonconformance, a deviation or a CAPA, each process is intended to evaluate and mitigate the immediate risk posed by an issue. Long-term systemic risks are then exposed by tracking and analyzing the recurrence of similar issues. A consistent approach in assessing risk is an important factor for successful quality management.
How Can MasterControl Risk Analysis Software System Help You with Risk Analysis? MasterControl Risk Analysis™ establishes risk evaluation as a separate process. The output is a risk score based on a consistent process, which enables quality departments to reduce the oftentimes subjective nature of quality decision making.
Here are some examples of how MasterControl Risk Analysis is helping companies efficiently manage a consistent risk evaluation process as an input to different quality-related processes such as nonconformance, deviation, CAPA, and more.


- Best-Practice Form: A pre-configured, multi-page form prompts participants to collect and track all relevant data and guides them through the process while allowing responsible personnel to make decisions appropriately. The form is automatically routed to the appropriate personnel and can be escalated if not processed in a timely manner.
- Best-Practice Process: MasterControl incorporates a two-step process that guides users through the process, including Risk Analysis Performance and Risk Analysis Approval.
- Analytics Reporting Tool: This built-in tool comes with a standard set of pre-configured reports that can be adjusted and customized by the end user. Risk Analyses can be analyzed by source and other parameters. These data-mining capabilities can give important insight into systemic quality issues and serve as yet another starting point for CAPA.
- Audit Trail and Electronic Signatures: MasterControl provides time-stamped audit trail, reporting, and electronic signature capabilities that fully satisfy FDA’s 21 CFR Part 11 and other global regulatory requirements.
|